Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| XWELL, Inc.XWEL · Entity 1233 | Director | January 05, 2023 | January 10, 2023 |
| Xperi CorpXPER · Entity 148740 | Director | April 17, 2017 | April 19, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
XWELL, Inc.
Report date January 05, 2023 · Filed January 10, 2023 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.40 · Expires 2033-01-05 | Direct | 300,000 |
Reported balance
After 2023-01-05 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2023-01-05 · Grant · Acquired 300,000 · Balance 300,000 F1: This grant is pursuant to the directors compensation plan. F2: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant is pursuant to the directors compensation plan.
F2: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023.
Xperi Corp
Report date April 17, 2017 · Filed April 19, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,370 |
Reported balance
After 2017-04-17 transaction · row 1
1 source rowRow 1 · 2017-04-17 · Sale · Disposed 1,900 · Balance 21,370 F1: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares. F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $31.60 to $32.10 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares.
F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $31.60 to $32.10 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 05, 2023 Filed Jan 10, 2023 02:36 UTC Amendment | XWELL, Inc. XWEL · Entity 1233 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001235110-23-000003 · edgar.xml · derivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-01-05 F1 · security: This grant is pursuant to the directors compensation plan. F2 · derivative.exercise_date: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 19:52 UTC | XWELL, Inc. XWEL · Entity 1233 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0000950138-23-000006 · edgar.xml · derivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2033-01-05 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · derivative.exercise_date: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2023. Read SEC document |
| January 26, 2022 Filed Feb 1, 2022 01:15 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (right to buy) · Derivative | 46,875 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0000950138-22-000032 · edgar.xml · derivative · entry 2 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common Stock · 46,875 shares Expires 2032-01-26 F3 · derivative.exercise_date: The options vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022. Read SEC document |
| January 26, 2022 Filed Feb 1, 2022 01:15 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantCommon Stock | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-22-000032 · edgar.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,485 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · shares: Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022. Read SEC document |
| July 29, 2021 Filed Aug 3, 2021 10:24 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000398 · edgar.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,235 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · shares: Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of June 30, 2022. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:36 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (right to buy) · Derivative | 43,077 | $0.00 Strike: $1.19 | $0.00 |
DisclosureSEC source: 0001235110-21-000003 · edgar.xml · derivative · entry 2 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,077 Underlying: Common Stock · 43,077 shares Expires 2031-01-04 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F3 · derivative.exercise_date: The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2021. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:36 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantCommon Stock | 28,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001235110-21-000003 · edgar.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,235 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F2 · balance_after: Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2021. Read SEC document |
| April 20, 2020 Filed Apr 21, 2020 23:58 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001104659-20-049353 · tm2016454d4_4.xml · derivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2030-04-20 F1 · security: These securities were issued as part of the Issuer's equity grant to directors. F1 · price: These securities were issued as part of the Issuer's equity grant to directors. F2 · derivative.exercise_date: The shares underlying this option vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2020. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:28 UTC | XWELL, Inc. XSPA · Entity 1233 | GrantStock Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001144204-19-007334 · tv513327_form4.xml · derivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2029-02-11 F1 · security: These securities were issued as part of the Issuer's annual equity grant to directors. F1 · price: These securities were issued as part of the Issuer's annual equity grant to directors. F2 · derivative.exercise_date: The shares underlying this option vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2019. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 17:09 UTC | Xperi Corp XPER · Entity 148740 | SaleCommon Stock | 1,900 | $31.81 | $60,439.95 |
DisclosureSEC source: 0001209191-17-027497 · doc4.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,370 F1 · kind: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $31.60 to $32.10 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| March 15, 2017 Filed Mar 20, 2017 17:02 UTC | Xperi Corp XPER · Entity 148740 | SaleCommon Stock | 1,900 | $34.42 | $65,390.59 |
DisclosureSEC source: 0001209191-17-021763 · doc4.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,270 F1 · kind: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $34.25 to $34.60 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 17:14 UTC | Xperi Corp TSRA · Entity 148740 | SaleCommon Stock | 1,900 | $43.91 | $83,429.95 |
DisclosureSEC source: 0001209191-17-011570 · doc4.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,170 F1 · kind: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $43.60 to $44.15 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| January 17, 2017 Filed Jan 19, 2017 17:05 UTC | Xperi Corp TSRA · Entity 148740 | SaleCommon Stock | 1,900 | $43.70 | $83,024.11 |
DisclosureSEC source: 0001209191-17-004574 · doc4.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,070 F1 · kind: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $43.50 to $44.20 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request. Read SEC document |
| January 17, 2017 Filed Jan 20, 2017 22:42 UTC | XWELL, Inc. FH · Entity 1233 | GrantStock Option · Derivative | 80,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001144204-17-003260 · v456886_4.xml · derivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-01-17 F1 · security: These securities were issued as part of the Issuer's annual equity compensation to non-employee directors. F1 · price: These securities were issued as part of the Issuer's annual equity compensation to non-employee directors. F2 · derivative.exercise_date: These options to purchase shares of common stock of the Issuer vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter thereafter. Read SEC document |
| December 30, 2016 Filed Jan 3, 2017 19:41 UTC | Xperi Corp TSRA · Entity 148740 | SaleCommon Stock | 1,900 | $44.38 | $84,323.14 |
DisclosureSEC source: 0001209191-17-000485 · doc4.xml · nonDerivative · entry 1 Stout Donald E. · CIK 0001509502 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,970 F1 · kind: The sale is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $44.15 to $44.65 per share. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.